Startups
FabRx is a specialist biotech company, focused on developing 3D printing technology for fabricating pharmaceuticals and medical devices.
Overview
Location
United Kingdom, England, London
Employees
1-10
Founded date
2014
Mentions in press and media 12
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 4, 2025 | VERIGRAFT Secures €1.2M Eurostars Grant for 3D Printed Vascular Graft Breakthrough | VERIGRAFT, a Swedish biotechnology company specializing in regenerative medicine, has been awarded a €1.2 million Eurostars grant for the PREPPER (PREcision Printed PERsonalized Tissue Therapies) project. The initiative is a collaboration w... |
| Mar 3, 2025 | The Future of Medicine: 3D Printing Takes Center Stage | In the heart of Montpellier, a revolution is brewing. MB Therapeutics, a startup with a vision, has secured €2 million in seed funding. This money is not just a lifeline; it’s a launchpad. The goal? To create the first pharmaceutical facili... |
| Feb 25, 2025 | MB Therapeutics €2 Million Seed Funding to Support Personalized Medicine Production | MB Therapeutics, a Montpellier-based startup with over 8 years of expertise in pharmaceutical 3D printing, has secured €2 million in seed funding to develop the first pharmaceutical facility designed to provide 3D printing compatible soluti... |
| Feb 7, 2023 | FabRx optimizes medicine manufacturing by integration of pressure sensor control in SSE 3D printing | UK-based biotech company FabRx has announced the official launch of its new pressure-detecting semi-solid extruder (SSE) printhead; the SSE Laguna. To guarantee print uniformity while printing semi-solid doses, this new patent-protected qua... |
| Jul 23, 2022 | 3D printed cornea transplants at Precise Bio gain new R&D funding from Carl Zeiss Meditec | US biotechnology start-up Precise Bio has gained the backing of Carl Zeiss Meditec to fund the further development of its 3D printed cornea transplants. Precise Bio is currently honing endothelial keratoplasty and natural lenticule transpla... |
| Jun 10, 2022 | 42 start-ups through to Catapult 2022-23 semifinals | We are excited to today announce the 42 promising start-ups that will go through to the semifinals of EIT Health Catapult 2022-23. Each year, the competition showcases Europe’s most promising biotech, medtech and digital health start-ups to... |
| Mar 10, 2022 | Evonik invests in Laxxon Medical for mass production of 3D printed pharmaceuticals | The venture capital arm of German chemicals firm Evonik has invested in Nevada-based 3D printed pharmaceutical firm Laxxon Medical to bring the mass production of 3D printed tablets closer to reality. The firms are partnering to fabricate n... |
| Feb 28, 2022 | CurifyLabs and Natural Machines to launch affordable, “pharma-compliant” drug 3D printing technology in 2022 | Pharmaceutical customization technology developer CurifyLabs has partnered with food printing firm Natural Machines with the aim of bringing a new low-cost drug 3D printer to market. Working together, the companies say they’ve developed a “... |
| Feb 21, 2022 | Volumetric 3D printing speeds up on-demand pharmaceutical drug production | Researchers have used volumetric 3D printing to fabricate drug-loaded tablets within a matter of seconds, reportedly for the first time. Hailing from University College London (UCL), the University of Santiago de Compostela (USC), the MERLN... |
Show more
Reviews 0
FAQ about FabRx
When was FabRx founded?
FabRx was founded in 2014.
What has the press written about FabRx?
Parsers VC has collected 12 articles mentioning FabRx, among them “VERIGRAFT Secures €1.2M Eurostars Grant for 3D Printed Vascular Graft Breakthrough” (Mar 4, 2025) and “The Future of Medicine: 3D Printing Takes Center Stage” (Mar 3, 2025).
Is FabRx still active?
Yes, FabRx is active; its latest activity on Parsers VC dates from Jul 8, 2026.